Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
New Jersey-based Johnson & Johnson said Wednesday it would buy Pennsylvania-based Synthes Inc. in a stock-heavy acquisition likely to pass antitrust muster that values the Swiss medical device maker at $21.3...To view the full article, register now.
Already a subscriber? Click here to view full article